基于CRISPR/Cas系统的噬菌体基因组编辑

doi:10.16288/j.yczz.17-419

遗传 ›› 2018, Vol. 40 ›› Issue (5): 378-389.doi: 10.16288/j.yczz.17-419

基于CRISPR/Cas系统的噬菌体基因组编辑

梁彩娇,孟繁梅,艾云灿()

中山大学生命科学学院,有害生物控制与资源利用国家重点实验室,广州 510275

收稿日期:2017-12-25 修回日期:2018-02-06 出版日期:2018-05-20 发布日期:2018-04-04
通讯作者: 艾云灿 E-mail:Lssayc@mail.sysu.edu.cn
作者简介:梁彩娇,硕士研究生,研究方向：微生物学。E-mail: 515059960@qq.com
基金资助:
国家科技重大专项(2014ZX0801105B002);国家高技术研究发展计划(863计划)项目资助(2006AA09Z420)

CRISPR/Cas systems in genome engineering of bacteriophages

Liang Caijiao,Meng Fanmei,Ai Yuncan()

State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou 510275, China

Received:2017-12-25 Revised:2018-02-06 Online:2018-05-20 Published:2018-04-04
Contact: Ai Yuncan E-mail:Lssayc@mail.sysu.edu.cn
Supported by:
Supported by the National Science and Technology Major Project of China(2014ZX0801105B002);and the National High Technology Research & Development Project(2006AA09Z420)

摘要/Abstract

摘要：

对原核生物获得性免疫系统CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR- associated genes)的研究促进了新一代基因组编辑工具的产生和发展。噬菌体既是原核生物CRISPR阵列(CRISPR array)进化的原动力,又是CRISPR/Cas系统防御的对象。噬菌体功能基因组学研究的速率却落后于发现新噬菌体和测定基因组序列的速率。基于CRISPR/Cas系统的噬菌体基因组编辑,可为噬菌体功能基因组学研究提供新手段。本文评述了基于CRISPR/Cas系统编辑噬菌体基因组的几例开创性研究,并且比较了多种操作程序的异同点和优缺点。同时,进一步构建了联合使用CRISPR/Cas系统与噬菌体重组系统开展噬菌体基因组编辑的新方案,讨论了新方案的潜在局限性,并对如何选择不同方案给予了建议。

关键词: CRISPR/Cas系统, 噬菌体, 基因组编辑, 同源重组

Abstract:

Researches on CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated genes) systems, that are adaptive immunity systems encoded by prokaryotes, have promoted the development of new genome-editing tools. Bacteriophages are not only the driving elements for the evolution of prokaryotes’ CRISPR arrays, but also the targets of the CRISPR/Cas systems. Studies on functional genomics of bacteriophages have been lagging behind the discovery of new phage strains and the sequencing of their genomes. CRISPR/Cas systems-driven genome engineering of bacteriophages provides a novel approach for bacteriophage functional genomics. This review comments on a few profound cases of genome engineering of bacteriophages that employed the CRISPR/Cas systems, and compares multiple procedures illustrating common or distinct features as well as advantages and disadvantages underlying each procedure. We design new applications of the CRISPR/Cas systems coupled with bacteriophage recombination systems, discuss their potential constraints, and offer suggestions for each option.

Key words: CRISPR/Cas systems, bacteriophage, genome editing, homologous recombination

梁彩娇, 孟繁梅, 艾云灿. 基于CRISPR/Cas系统的噬菌体基因组编辑[J]. 遗传, 2018, 40(5): 378-389.

Liang Caijiao, Meng Fanmei, Ai Yuncan. CRISPR/Cas systems in genome engineering of bacteriophages[J]. Hereditas(Beijing), 2018, 40(5): 378-389.

参考文献

[1]	Bergh O, Børsheim KY, Bratbak G, Heldal M . High abundance of viruses found in aquatic environments. Nature, 1989,340(6233):467-468.
[2]	Danovaro R , Dell'Anno A, Trucco A, Serresi M, Vanucci S. Determination of virus abundance in marine sediments. Appl Environ Microbiol, 2001,67(3):1384-1387.
[3]	Williamson KE, Radosevich M, Wommack KE . Abundance and diversity of viruses in six Delaware soils. Appl Environ Microbiol, 2005,71(6):3119-3125.
[4]	Rohwer F . Global phage diversity. Cell, 2003,113(2):141.
[5]	Pope WH, Bowman CA, Russell DA, Jacobs-Sera D, Asai DJ, Cresawn SG, Jacobs WR, Hendrix RW, Lawrence JG, Hatfull GF . Whole genome comparison of a large collection of mycobacteriophages reveals a continuum of phage genetic diversity. eLife, 2015,4:e06416.
[6]	Grissa I, Vergnaud G, Pourcel C . The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics, 2007,8(1):172.
[7]	Seed KD, Lazinski DW, Calderwood SB, Camilli A . A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity. Nature, 2013,494(7438):489-491.
[8]	Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, Saunders SJ, Barrangou R, Brouns SJJ, Charpentier E, Haft DH, Horvath P, Moineau S, Mojica FJM, Terns RM, Terns MP, White MF, Yakunin AF, Garrett RA , Van Der Oost J, Backofen R, Koonin EV. An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol, 2015,13(11):722-736.
[9]	Shmakov S, Smargon A, Scott D, Cox D, Pyzocha N, Yan W, Abudayyeh OO, Gootenberg JS, Makarova KS, Wolf YI, Severinov K, Zhang F, Koonin EV . Diversity and evolution of class 2 CRISPR-Cas systems. Nat Rev Microbiol, 2017,15(3):169-182.
[10]	Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao YJ, Pirzada ZA, Eckert MR, Vogel, Charpentier E . CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature, 2011,471(7340):602-607.
[11]	Walker FC, Chou-Zheng L, Dunkle JA, Hatoum-Aslan A . Molecular determinants for CRISPR RNA maturation in the Cas10-Csm complex and roles for non-Cas nucleases. Nucleic Acids Res, 2017,45(4):2112-2123.
[12]	Levy A, Goren MG, Yosef I, Auster O, Manor M, Amitai G, Edgar R, Qimron U, Sorek R . CRISPR adaptation biases explain preference for acquisition of foreign DNA. Nature, 2015,520(7548):505-510.
[13]	Wang JY, Li JZ, Zhao HT, Sheng G, Wang M, Yin ML, Wang YL . Structural and mechanistic basis of PAM-dependent spacer acquisition in CRISPR-Cas systems. Cell, 2015,163(4):840-853.
[14]	Nuñez JK, Lee ASY, Engelman A, Doudna JA . Integrase- mediated spacer acquisition during CRISPR-Cas adaptive immunity. Nature, 2015,519(7542):193-198.
[15]	Brouns SJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJ, Snijders AP, Dickman MJ, Makarova KS, Koonin EV , Van Der Oost J. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science, 2008,321(5891):960-964.
[16]	Hayes RP, Xiao YB, Ding F, Van Erp PBG, Rajashankar K, Bailey S, Wiedenheft B, Ke AL . Structural basis for promiscuous PAM recognition in type I-E Cascade from E. coli. Nature, 2016,530(7591):499-503.
[17]	Hochstrasser ML, Taylor DW, Bhat P, Guegler CK, Sternberg SH, Nogales E, Doudna JA . CasA mediates Cas3- catalyzed target degradation during CRISPR RNA-guided interference. Proc Natl Acad Sci USA, 2014,111(18):6618-6623.
[18]	Vorontsova D, Datsenko KA, Medvedeva S, Bondy- Denomy J, Savitskaya EE, Pougach K, Logacheva M, Wiedenheft B, Davidson AR, Severinov K, Semenova E . Foreign DNA acquisition by the I-F CRISPR-Cas system requires all components of the interference machinery. Nucleic Acids Res, 2015,43(22):10848-10860.
[19]	Haurwitz RE, Jinek M, Wiedenheft B, Zhou KL, Doudna JA . Sequence-and structure-specific RNA processing by a CRISPR endonuclease. Science, 2010,329(5997):1355-1358.
[20]	Rollins MF, Chowdhury S, Carter J, Golden SM, Wilkinson RA, Bondy-Denomy J, Lander GC, Wiedenheft B . Cas1 and the Csy complex are opposing regulators of Cas2/3 nuclease activity. Proc Natl Acad Sci USA, 2017,114(26):E5113-E5121.
[21]	Heler R, Samai P, Modell JW, Weiner C, Goldberg GW, Bikard D, Marraffini LA . Cas9 specifies functional viral targets during CRISPR-Cas adaptation. Nature, 2015,519(7542):199-202.
[22]	Anders C, Niewoehner O, Duerst A, Jinek M . Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature, 2014,513(7519):569-573.
[23]	Tamulaitis G, Kazlauskiene M, Manakova E, Venclovas C, Nwokeoji AO, Dickman MJ, Horvath P, Siksnys V . Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus. Mol Cell, 2014,56(4):506-517.
[24]	Goldberg GW, Jiang WY, Bikard D, Marraffini LA . Conditional tolerance of temperate phages via transcription- dependent CRISPR-Cas targeting. Nature, 2014,514(7524):633-637.
[25]	Samai P, Pyenson N, Jiang WY, Goldberg GW, Hatoum-Aslan A, Marraffini LA . Co-transcriptional DNA and RNA cleavage during type III CRISPR-Cas immunity. Cell, 2015,161(5):1164-1174.
[26]	Mojica FJM, Díez-Villaseñor C, García-Martiñez J, Soria E . Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol, 2005,60(2):174-182.
[27]	Martel B, Moineau S . CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages. Nucleic Acids Res, 2014,42(14):9504-9513.
[28]	Garneau JE, Dupuis ME, Villion M, Romero DA, Barrangou R, Boyaval P, Fremaux C, Horvath P, Magadán AH, Moineau S . The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature, 2010,468(7320):67-71.
[29]	Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E . A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 2012,337(6096):816-821.
[30]	Tao P, Wu XR, Tang WC, Zhu JG, Rao V . Engineering of bacteriophage T4 genome using CRISPR-Cas9. ACS Synth Biol, 2017,6(10):1952-1961.
[31]	Bari SMN, Walker FC, Cater K, Aslan B, Hatoum-Aslan A . Strategies for editing virulent staphylococcal phages using CRISPR-Cas10. ACS Synth Biol, 2017,6(12):2316-2325.
[32]	Marraffini LA, Sontheimer EJ . CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science, 2008,322(5909):1843-1845.
[33]	Staals RH, Zhu YF, Taylor DW, Kornfeld JE, Sharma K, Barendregt A, Koehorst JJ, Vlot M, Neupane N, Varossieau K, Sakamoto K, Suzuki T, Dohmae N, Yokoyama S, Schaap PJ, Urlaub H, Heck AJR, Nogales E, Doudna JA, Shinkai A , Van Der Oost J. RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus. Mol Cell, 2014,56(4):518-530.
[34]	Marraffini LA, Sontheimer EJ . Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature, 2010,463(7280):568-571.
[35]	Hynes AP, Labrie SJ, Moineau S . Programming native CRISPR arrays for the generation of targeted immunity. mBio, 2016,7(3):e00202-16.
[36]	Tamulaitis G, Venclovas Č, Siksnys V . Type Ⅲ CRISPR- Cas immunity: major differences brushed aside. Trends Microbiol, 2017,25(1):49-61.
[37]	Kiro R, Shitrit D, Qimron U . Efficient engineering of a bacteriophage genome using the type Ⅰ-E CRISPR-Cas system. RNA Biol, 2014,11(1):42-44.
[38]	Huo YW, Nam KH, Ding F, Lee H, Wu LJ, Xiao YB, Farchione MD, Jr, Zhou S , Rajashankar K, Kurinov I, Zhang RG, Ke AL. Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation. Nat Struct Mol Biol, 2014,21(9):771-777.
[39]	Westra ER, Van Erp PB, Künne T, Wong SP, Staals RH, Seegers CLC, Bollen S, Jore MM, Semenova E, Severinov K, De Vos WM, Dame RT, De Vries R, Brouns SJ , Van Der Oost J. CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol Cell, 2012,46(5):595-605.
[40]	Box AM , McGuffie MJ, O'Hara BJ, Seed KD. Functional analysis of bacteriophage immunity through a type I-E CRISPR-Cas system in Vibrio cholerae and its application in bacteriophage genome engineering. J Bacteriol, 2015,198(3):578-590.
[41]	Lemay ML, Tremblay DM, Moineau S . Genome engineering of virulent lactococcal phages using CRISPR- Cas9. ACS Synth Biol, 2017,6(7):1351-1358.
[42]	Datta S, Costantino N, Zhou XM, Court DL . Identification and analysis of recombineering functions from Gram- negative and Gram-positive bacteria and their phages. Proc Natl Acad Sci USA, 2008,105(5):1626-1631.
[43]	Jiang WY, Bikard D, Cox D, Zhang F, Marraffini LA . RNA-guided editing of bacterial genomes using CRISPR- Cas systems. Nat Biotechnol, 2013,31(3):233-239.
[44]	Costantino N, Court DL . Enhanced levels of λ Red-mediated recombinants in mismatch repair mutants. Proc Natl Acad Sci USA, 2003,100(26):15748-15753.
[45]	Muyrers JPP, Zhang YM, Buchholz F, Stewart AF . RecE/ RecT and Redalpha/Redbeta initiate double-stranded break repair by specifically interacting with their respective partners. Genes Dev, 2000,14(15):1971-1982.
[46]	Oppenheim AB, Rattray AJ, Bubunenko M, Thomason LC, Court DL . In vivo recombineering of bacteriophage λ by PCR fragments and single-strand oligonucleotides. Virology, 2004,319(2):185-189.
[47]	Marinelli LJ, Piuri M, Swigoňová Z, Balachandran A, Oldfield LM, Van Kessel JC, Hatfull GF . BRED: a simple and powerful tool for constructing mutant and recombinant bacteriophage genomes. PLoS One, 2008,3(12):e3957.
[48]	Van Kessel JC, Marinelli LJ, Hatfull GF . Recombineering mycobacteria and their phages. Nat Rev Microbiol, 2008,6(11):851-857.
[49]	Park JY, Moon BY, Park JW, Thornton JA, Park YH, Seo KS . Genetic engineering of a temperate phage-based delivery system for CRISPR/Cas9 antimicrobials against Staphylococcus aureus. Sci Rep, 2017,7:44929.
[50]	Bikard D, Euler CW, Jiang W, Nussenzweig PM, Goldberg GW, Duportet X, Fischetti VA, Marraffini LA . Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol, 2014,32(11):1146-1150.
[51]	Van Kessel JC, Hatfull GF . Efficient point mutagenesis in mycobacteria using single-stranded DNA recombineering: characterization of antimycobacterial drug targets. Mol Microbiol, 2008,67(5):1094-1107.
[52]	Edgar R, Qimron U . The Escherichia coli CRISPR system protects from λ lysogenization, lysogens, and prophage induction. J Bacteriol, 2010,192(23):6291-6294.
[53]	Nozawa T, Furukawa N, Aikawa C, Watanabe T, Haobam B, Kurokawa K, Maruyama F, Nakagawa I . CRISPR inhibition of prophage acquisition in Streptococcus pyogenes. PLoS One, 2011,6(5):e19543.
[54]	Samson JE, Magadán AH, Sabri M, Moineau S . Revenge of the phages: defeating bacterial defences. Nat Rev Microbiol, 2013,11(10):675-687.
[55]	Bondy-Denomy J, Pawluk A, Maxwell KL, Davidson AR . Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature, 2013,493(7432):429-432.
[56]	Bondy-Denomy J, Garcia B, Strum S, Du MJ, Rollins MF, Hidalgo-Reyes Y, Wiedenheft B, Maxwell KL, Davidson AR . Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins. Nature, 2015,526(7571):136-139.
[57]	Rauch BJ, Silvis MR, Hultquist JF, Waters CS, McGregor MJ, Krogan NJ , Bondy-Denomy J. Inhibition of CRISPR- Cas9 with bacteriophage proteins. Cell, 2017, 168(1-2): 150- 158. e10.
[58]	Hynes AP, Rousseau GM, Lemay ML, Horvath P, Romero DA, Fremaux C, Moineau S . An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9. Nat Microbiol, 2017,2(10):1374-1380.
[59]	Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P . CRISPR provides acquired resistance against viruses in prokaryotes. Science, 2007,315(5819):1709-1712.
[60]	Abudayyeh OO, Gootenberg JS, Konermann S, Joung JJ, Slaymaker IM, Cox DB, Shmakov S, Makarova KS, Semenova E, Minakhin L, Severinov K, Regev A, Lander ES, Koonin EV , Zhang F. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science, 2016, 353(6299): aaf5573.
[61]	Meng FM, Zhang CH, Ai YC . Advances of development of phage display systems. Hereditas (Beijing), 2011,33(10):1113-1120.
[61]	孟繁梅, 张朝辉, 艾云灿 . 噬菌体展示技术系统发展进展. 遗传, 2011,33(10):1113-1120.
[62]	Salmond GPC, Fineran PC . A century of the phage: past, present and future. Nat Rev Microbiol, 2015,13(12):777-786.
[63]	Pires DP, Cleto S, Sillankorva S, Azeredo J, Lu TK . Genetically engineered phages: a review of advances over the last decade. Microbiol Mol Biol Rev, 2016,80(3):523-543.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

基于CRISPR/Cas系统的噬菌体基因组编辑

CRISPR/Cas systems in genome engineering of bacteriophages

RichHTML

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	王珏, 黄娟, 许蕊. 利用CRISPR/Cas9和piggyBac实现果蝇基因组无缝编辑[J]. 遗传, 2019, 41(5): 422-429.
[2]	李帆, 余蓉培, 孙丹, 王继华, 李绅崇, 阮继伟, 单芹丽, 陆平利, 汪国鲜. 抑制植物减数分裂重组的分子机理[J]. 遗传, 2019, 41(1): 52-65.
[3]	全绒, 李国玲, 莫健新, 钟翠丽, 李紫聪, 顾婷, 郑恩琴, 刘德武, 蔡更元, 吴珍芳, 张献伟. RNA干扰猪NHEJ通路修复因子对HR效率的影响[J]. 遗传, 2018, 40(9): 749-757.
[4]	童晓玲,方春燕,盖停停,石津,鲁成,代方银. CRISPR/Cas9系统在昆虫中的应用[J]. 遗传, 2018, 40(4): 266-278.
[5]	李明,程飞跃,龚路遥,向华. 微生物新型防御系统的系统性发现与展望[J]. 遗传, 2018, 40(4): 259-265.
[6]	刘佳伟,洪涛,秦鑫,梁英民,张萍. β-血红蛋白病基因组编辑治疗的研究进展[J]. 遗传, 2018, 40(2): 95-103.
[7]	刘春霞, 耿立召, 许建平. 植物基因组编辑检测方法[J]. 遗传, 2018, 40(12): 1075-1091.
[8]	黄敏,杨业然,孙晓艳,张婷,郭彩霞. RAD51调控REV1参与DNA双链断裂修复[J]. 遗传, 2018, 40(11): 1007-1014.
[9]	贺燕,谢梦女,余立,任真,朱芳,符淳. 范可尼贫血基因在卵泡发育中的调节作用[J]. 遗传, 2017, 39(6): 469-481.
[10]	李红花,刘钢. CRISPR/Cas9在丝状真菌基因组编辑中的应用[J]. 遗传, 2017, 39(5): 355-367.
[11]	李国玲,钟翠丽,莫健新,全绒,吴珍芳,李紫聪,杨化强,张献伟. 动物基因组定点整合转基因技术研究进展[J]. 遗传, 2017, 39(2): 98-109.
[12]	黄娇娇, 曹春伟, 郑国民, 赵建国. 基因组编辑技术在猪遗传改良中的应用[J]. 遗传, 2017, 39(11): 1078-1089.
[13]	马三垣,夏庆友. 家蚕遗传育种：从传统杂交到分子设计[J]. 遗传, 2017, 39(11): 1025-1032.
[14]	王伟, 王玉霜, 黄兰兰, 简子健, 王新华, 刘守仁, 皮文辉. siRNA干扰绵羊胚胎成纤维细胞Lig4基因增加同源重组载体重连修复效率[J]. 遗传, 2016, 38(9): 831-839.
[15]	刘丁源, 邱婷, 丁晓辉, 李苗苗, 朱睦元, 王君晖. 快速构建多重sgRNA载体利用CRISPR/Cas9技术敲除拟南芥IAA2基因[J]. 遗传, 2016, 38(8): 756-764.